PTC124 improves readthrough and increases enzymatic activity of the CPT1A R160X nonsense mutation.
Deficiency of carnitine palmitoyltransferase 1A (CPT1A) results in impaired hepatic long-chain fatty acid oxidation and ketogenesis. We have previously described a patient with a severe CPT1A phenotype who is homozygous for the nonsense mutation 478 C > T (R160X). It has been known for some time that gentamicin can promote readthrough of nonsense codons. Recently, a new compound (PTC124) with less clinical toxicity than gentamicin has been indicated as a therapy for patients with nonsense mutations for multiple genetic diseases. The study is designed to investigate whether PTC124 can promote readthrough of the R160X CPT1A mutation and increase normal sized CPT1 protein expression and activity in the patient's skin fibroblasts. Our study demonstrated that after both PTC 124 and gentamicin treatment, there was an increase in CPT1 activity in patient fibroblasts to levels that are similar to that of the mild Inuit P479L variant. Our results provide additional evidence for proof of principle that PTC124 is a potential therapeutic agent for treating patients with any genetic condition that results from a nonsense mutation.
Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Lu
L
Tan
Srinivas B
SB
Narayan
Jie
J
Chen
Gail Ditewig
GD
Meyers
Michael J
MJ
Bennett
D002334:Carnitine O-Palmitoyltransferase / Q000235:genetics*; D002675:Child, Preschool; D003062:Codon; D018389:Codon, Nonsense; D005227:Fatty Acids / Q000737:chemistry; D005260:Female; D005347:Fibroblasts / Q000166:cytology / Q000378:metabolism; D005839:Gentamicins / Q000494:pharmacology; D006720:Homozygote; D006801:Humans; D022124:Hyperammonemia / Q000235:genetics; D007003:Hypoglycemia / Q000235:genetics; D007659:Ketones / Q000378:metabolism; D008107:Liver Diseases / Q000235:genetics; D009154:Mutation; D010069:Oxadiazoles / Q000737:chemistry*; D010100:Oxygen / Q000737:chemistry; D010641:Phenotype; D012867:Skin / Q000378:metabolism
D003062:Codon; D018389:Codon, Nonsense; D005227:Fatty Acids; D005839:Gentamicins; D007659:Ketones; D010069:Oxadiazoles; D002334:Carnitine O-Palmitoyltransferase; C515878:ataluren; D010100:Oxygen
J Biol Chem. 1996 Mar 22;271(12):6972-7
8636126
Mol Genet Metab. 2009 Apr;96(4):201-7
19217814
Mol Genet Metab. 2009 Aug;97(4):244-9
19427250
Lancet. 2008 Aug 30;372(9640):719-27
18722008
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2064-9
18272502
Audiol Neurootol. 2000 Jan-Feb;5(1):3-22
10686428
J Lipid Res. 2009 Jun;50(6):1223-8
19181627
Nature. 2007 May 3;447(7140):87-91
17450125
Mol Genet Metab. 2004 May;82(1):59-63
15110323
Drug Metab Pharmacokinet. 2004 Jun;19(3):159-70
15499183
Nature. 2007 May 3;447(7140):42-3
17450128
J Child Neurol. 2010 Sep;25(9):1158-64
20519671
J Lipid Res. 2001 Jul;42(7):1134-42
11441142